Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZAVZPRET safely and effectively. See full prescribing information for ZAVZPRET. ZAVZPRET™ (zavegepant) nasal spray Initial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
ZAVZPRET is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use ZAVZPRET is not indicated for the preventive treatment of migraine.
- generic_name
- zavegepant
- product_names
- zavegepant
- ndc
- 63539-135, 63539-135-01, 63539-135-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en